Cleancard
Making cancer detection as easy as a pregnancy test
San Francisco, United States · Founded 2021 · $5.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2021
- Website
- cleancard.bio
- Total Funding
- $5.0M
- Last Round
- $5.0M SeedSep 2023
- Rounds
- 1
About
We are combining synthetic biology and artificial intelligence to make cancer detection as easy as a pregnancy test. Cleancard's mission is to bring lab-grade diagnostics into the comfort of your home. Our novel method enables robust diagnostics and biomarker tracking from the urine. We are currently developing fully at-home, 30-minute tests for cancer using this methodology. We are constantly expanding the number of conditions we can detect from a single sample with our platform technology.
Summary
Cleancard is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. It has raised $5.0M in total across 1 round, most recently a $5.0M Seed round in Sep 2023. Investors include TQ Ventures and Urban Innovation Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2023
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company